Excedrin and Pioglitazone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Excedrin (acetaminophen; aspirin; caffeine) and Pioglitazone (pioglitazone hydrochloride). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Excedrin and Pioglitazone. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Excedrin?

Excedrin has active ingredients of acetaminophen; aspirin; caffeine. It is often used in headache. eHealthMe is studying from 22,740 Excedrin users. Check the latest studies of Excedrin.

What is Pioglitazone?

Pioglitazone has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 12,864 Pioglitazone users. Check the latest studies of Pioglitazone.



On Jul, 19, 2026

19 people who take Excedrin and Pioglitazone together, and have interactions are studied.

Excedrin and Pioglitazone drug interactions.

What are the common drug interactions of Excedrin and Pioglitazone, by gender? *:

female:

  1. Chronic kidney disease
  2. Depression
  3. Nausea (feeling of having an urge to vomit)
  4. Renal failure (kidney dysfunction)
  5. Abdominal distension
  6. Anxiety
  7. Arthralgia (joint pain)
  8. Arthropathy
  9. Asthma
  10. Back pain

male:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nausea (feeling of having an urge to vomit)
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  5. Renal failure (kidney dysfunction)
  6. Constipation
  7. Dementia (madness)
  8. Dyspepsia (indigestion)
  9. Fatigue (feeling of tiredness)
  10. Glaucoma (increased fluid pressure in the eye with vision loss)

What are the common drug interactions of Excedrin and Pioglitazone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Abdominal distension
  3. Anxiety
  4. Constipation
  5. Decreased appetite
  6. Depression
  7. Diarrhoea
  8. Joint injury
  9. Myalgia (muscle pain)
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Renal failure (kidney dysfunction)
  4. Arthralgia (joint pain)
  5. Asthma
  6. Back pain
  7. Balance disorder
  8. Cataract (clouding of the lens inside the eye)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Cough

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Nausea (feeling of having an urge to vomit)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal impairment (severely reduced kidney function)
  7. Thrombosis (formation of a blood clot inside a blood vessel)
  8. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  9. Arthropathy
  10. Constipation

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 63.16%
  2. High Blood Pressure: 9 people, 47.37%
  3. Infection: 9 people, 47.37%
  4. Multiple Allergies (allergy to multiple agents): 9 people, 47.37%
  5. Cough: 8 people, 42.11%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 36.84%
  7. Hypersensitivity: 7 people, 36.84%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 36.84%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 36.84%
  10. Eye Infection: 6 people, 31.58%

* Approximation only. Some reports may have incomplete information.

Do you take Excedrin and Pioglitazone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Excedrin and Pioglitazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Excedrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pioglitazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Excedrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pioglitazone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; aspirin; caffeine and pioglitazone hydrochloride (the active ingredients of Excedrin and Pioglitazone, respectively), and Excedrin and Pioglitazone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: